DE60230792D1 - Verfahren zur unterscheidung von morbus crohn von ulzerativer colitis und anderen magen-darm-erkrankungen durch nachweis des vorhandenseins von fäkalen antikörpern gegen saccharomyces cerevisiae - Google Patents

Verfahren zur unterscheidung von morbus crohn von ulzerativer colitis und anderen magen-darm-erkrankungen durch nachweis des vorhandenseins von fäkalen antikörpern gegen saccharomyces cerevisiae

Info

Publication number
DE60230792D1
DE60230792D1 DE60230792T DE60230792T DE60230792D1 DE 60230792 D1 DE60230792 D1 DE 60230792D1 DE 60230792 T DE60230792 T DE 60230792T DE 60230792 T DE60230792 T DE 60230792T DE 60230792 D1 DE60230792 D1 DE 60230792D1
Authority
DE
Germany
Prior art keywords
saccharomyces cerevisiae
colitis
ulzerative
distinction
crohn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60230792T
Other languages
English (en)
Inventor
James Hunter Boone
David Maxwell Lyerly
Tracy Dale Wilkins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Techlab Inc
Original Assignee
Techlab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Techlab Inc filed Critical Techlab Inc
Application granted granted Critical
Publication of DE60230792D1 publication Critical patent/DE60230792D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE60230792T 2001-10-26 2002-10-26 Verfahren zur unterscheidung von morbus crohn von ulzerativer colitis und anderen magen-darm-erkrankungen durch nachweis des vorhandenseins von fäkalen antikörpern gegen saccharomyces cerevisiae Expired - Lifetime DE60230792D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33581201P 2001-10-26 2001-10-26
US10/280,564 US6872540B2 (en) 2001-10-26 2002-10-25 Method and apparatus for distinguishing Crohn's disease from ulcerative colitis and other gastrointestinal diseases by detecting the presence of fecal antibodies to Saccharomyces cerevisiae
PCT/US2002/034353 WO2003036262A2 (en) 2001-10-26 2002-10-26 Method and apparatus for distinguishing crohn's disease from ulcerative colitis by detecting fecal antibodies to saccharomyces cerevisiae

Publications (1)

Publication Number Publication Date
DE60230792D1 true DE60230792D1 (de) 2009-02-26

Family

ID=26960364

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60230792T Expired - Lifetime DE60230792D1 (de) 2001-10-26 2002-10-26 Verfahren zur unterscheidung von morbus crohn von ulzerativer colitis und anderen magen-darm-erkrankungen durch nachweis des vorhandenseins von fäkalen antikörpern gegen saccharomyces cerevisiae

Country Status (7)

Country Link
US (2) US6872540B2 (de)
EP (1) EP1444519B1 (de)
AT (1) ATE420360T1 (de)
AU (1) AU2002349942B2 (de)
CA (1) CA2464466A1 (de)
DE (1) DE60230792D1 (de)
WO (1) WO2003036262A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4395070B2 (ja) 2002-06-25 2010-01-06 インデックス・ダイアグノスティックス・アクチエボラーグ 潰瘍性大腸炎を診断するための方法およびキット
WO2004022713A2 (en) * 2002-09-05 2004-03-18 Techlab, Inc. Method for distinguishing ulcerative colitis from crohn's disease by detecting the presence of fecal anti-neutrophil cytoplasmic antibodies (anca)
ATE395596T1 (de) * 2002-10-25 2008-05-15 Techlab Inc Diagnostisches panel ibd-first chek fur entzundliche darmerkrankung (ibd) und reizkolon
US7592150B2 (en) 2003-12-03 2009-09-22 Glycominds, Ltd Method for diagnosing diseases based on levels of anti-glycan antibodies
EP1692519B1 (de) * 2003-12-03 2010-06-02 Glycominds Ltd. Diagnostikverfahren mittels messungen der antiglykan-antikörper-spiegeln
US20070121939A1 (en) * 2004-01-13 2007-05-31 Interdigital Technology Corporation Watermarks for wireless communications
US7904723B2 (en) * 2005-01-12 2011-03-08 Interdigital Technology Corporation Method and apparatus for enhancing security of wireless communications
US7943328B1 (en) 2006-03-03 2011-05-17 Prometheus Laboratories Inc. Method and system for assisting in diagnosing irritable bowel syndrome
US20100094560A1 (en) * 2006-08-15 2010-04-15 Prometheus Laboratories Inc. Methods for diagnosing irritable bowel syndrome
US20080085524A1 (en) 2006-08-15 2008-04-10 Prometheus Laboratories Inc. Methods for diagnosing irritable bowel syndrome
WO2009069007A2 (en) * 2007-11-30 2009-06-04 Glycominds, Ltd. Composition and method for prediction of complicated disease course and surgeries in crohn's disease
EP2562544A1 (de) 2007-12-20 2013-02-27 InDex Diagnostics AB Kit zur Verwendung bei der Differenzierung von IBD und IBS und der weiteren Unterscheidung zwischen IBD-Krankheitstypen
WO2015067913A1 (en) 2013-11-07 2015-05-14 Diagnodus Limited Biomarkers
WO2021146562A1 (en) * 2020-01-15 2021-07-22 Board Of Regents Of The University Of Nebraska Anti-maa immunoglobulin isotypes in inflammatory bowel disease: diagnostic implications for ulcerative colitis
CN112708568B (zh) * 2021-01-29 2023-03-21 上海理工大学 一种具有缓解急性结肠炎功能的酿酒酵母
WO2024073721A1 (en) * 2022-09-30 2024-04-04 Kimberly-Clark Worldwide, Inc. Methods and absorbent articles for inhibiting fecal protease activity

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693043A (en) * 1985-03-22 1997-12-02 Massachusetts Institute Of Technology Catheter for laser angiosurgery
US4953247A (en) * 1988-05-09 1990-09-04 Hasty Charles E Air-operated body support device
US5359038A (en) 1992-07-14 1994-10-25 Eloy Padron Method for isolating immunoglobulin compounds in the feces
US5462852A (en) * 1992-10-28 1995-10-31 The Government Of The United States Of America, As Represented By The Secretary, Dhhs HIV Nucleocapsid protein capture assay and method of use
US6562629B1 (en) 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
US5932429A (en) 1996-04-12 1999-08-03 Cedars-Sinai Medical Center Methods of diagnosing clinical subtypes of crohn's disease
US5874233A (en) 1996-04-12 1999-02-23 Cedars-Sinai Medical Center Methods of diagnosing a clinical subtype of Crohn's disease with features of ulcerative colitis
US5855577A (en) * 1996-09-17 1999-01-05 Eclipse Surgical Technologies, Inc. Bow shaped catheter
US6042581A (en) * 1996-11-08 2000-03-28 Thomas J. Fogarty Transvascular TMR device and method
US5968741A (en) 1997-04-11 1999-10-19 Cedars-Sinai Medical Center Methods of diagnosing a medically resistant clinical subtype of ulcerative colitis
US6218129B1 (en) 1998-05-15 2001-04-17 Prometheus Laboratories, Inc. Inflammatory bowel disease first step assay system
US6572608B1 (en) * 1999-04-08 2003-06-03 Eric T. Lee Directional laser probe
US6667160B2 (en) * 2000-03-15 2003-12-23 Kenneth D. Fine Method for diagnosing immunologic food sensitivity
US6984230B2 (en) * 2000-04-07 2006-01-10 Synergetics, Inc. Directional laser probe

Also Published As

Publication number Publication date
ATE420360T1 (de) 2009-01-15
US6872540B2 (en) 2005-03-29
WO2003036262A3 (en) 2003-07-03
WO2003036262A2 (en) 2003-05-01
AU2002349942B2 (en) 2007-11-01
EP1444519A2 (de) 2004-08-11
EP1444519A4 (de) 2006-01-11
US20030143649A1 (en) 2003-07-31
US20050136495A1 (en) 2005-06-23
EP1444519B1 (de) 2009-01-07
CA2464466A1 (en) 2003-05-01

Similar Documents

Publication Publication Date Title
DE60230792D1 (de) Verfahren zur unterscheidung von morbus crohn von ulzerativer colitis und anderen magen-darm-erkrankungen durch nachweis des vorhandenseins von fäkalen antikörpern gegen saccharomyces cerevisiae
IL171020A (en) Methods for diagnosing or predicting susceptibility to types of crohn's disease
ATE395596T1 (de) Diagnostisches panel ibd-first chek fur entzundliche darmerkrankung (ibd) und reizkolon
Sandborn Serologic markers in inflammatory bowel disease: state of the art
DE69936523D1 (de) Assaysystem zur erstbehandlung von darmerkrankungen
IL171356A (en) Anti-interferon receptor antibody for treatment of inflammatory bowel disease
EE200300128A (et) Meetod allergeeniga seostuva immunoglobuliini detekteerimiseks proovis, patsiendi allergiate in vitro diagnoosimeetod, mikromaatrikskiip ja komplekt
DE602005022924D1 (de) Verfahren zur diagnose von morbus crohn
DK1563300T3 (da) Diagnostisk fremgangsmåde til cøliaki
ATE406578T1 (de) Candida-nachweis
ITRM20030386A0 (it) Metodo e test diagnostici basati sull'analisi citofluorimetrica dei linfociti t antigene-specifici.
ATE153769T1 (de) Prüfungskit
DE60336138D1 (de) Verfahren zur diagnostik von tuberkulose
BRPI0200986B8 (pt) método de determinação da presença de hcv em uma amostra
WO2006005728A3 (de) Verfahren zur detektion geometrischer strukturen in bildern
ATE408832T1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
WO2004022713A3 (en) Method for distinguishing ulcerative colitis from crohn's disease by detecting the presence of fecal anti-neutrophil cytoplasmic antibodies (anca)
BR0015288A (pt) Método e aparelho para o teste de um sensor
DK2095126T3 (da) Fremgangsmåde til påvisning af humant parvovirusantigen
DE69132144D1 (de) Menschliche phospholipase aktivierender proteinteil
DE60038557D1 (en) Assay
GB0223655D0 (en) Method of diagnosis
Ciarrocchi et al. Pros and Cons of serological testing in syphilis diagnosis and follow up
WO2005020799A3 (en) METHOD FOR MEASURING FCϵRII/CD23 IGE RECEPTOR IN HUMAN FECES AS AN INDICATOR OF A TH2 PREDOMINANT IMMUNE RESPONSE INVOLVED IN GASTROINTESTINAL ILLNESSES
DK0929812T3 (da) Diagnosehjælpemiddel samt fremgangsmåde til påvisning af drægtighed af drøvtyggere

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: MURGITROYD & COMPANY, 48149 MUENSTER

8364 No opposition during term of opposition